Provided by Tiger Trade Technology Pte. Ltd.

GENSCRIPT BIO

34.440
+1.0803.24%
Volume:34.78M
Turnover:1.19B
Market Cap:75.70B
PE:-17.87
High:34.760
Open:33.200
Low:32.500
Close:33.360
52wk High:35.220
52wk Low:10.360
Shares:2.20B
HK Float Shares:2.20B
Volume Ratio:0.51
T/O Rate:1.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.927
ROE:-15.33%
ROA:1.54%
PB:2.48
PE(LYR):-17.87
PS:11.43

Loading ...

BUZZ-Legend Biotech slides on $226 mln share sale

Reuters
·
Jun 18

Movement Alert|GenScript Biotech Rises 5.41% in Regular Trading, Recovering After Legend Biotech LB2501 Clinical Data Triggered Sell-the-News Pullback

Market Focus
·
Jun 18

Genscript Associate Reports Promising Phase 1 Data for LB2501 in B-Cell Lymphoma

MT Newswires Live
·
Jun 15

Genscript Biotech Share Price Plummets Despite Positive Trial Results from Associate Company

Stock News
·
Jun 15

Movement Alert|GenScript Biotech Falls 6.07% in Regular Trading, CXO Sector Sentiment Remains Fragile Amid US-China Biomedical Policy Uncertainty

Market Focus
·
Jun 15

GenScript Biotech: Associate Legend Achieves 100% ORR with First-in-Class Dual-Targeting CAR-T LB2501 in Early B-NHL Trial

Bulletin Express
·
Jun 14

Genscript Biotech's Affiliate Reports Proof of Concept for Novel In Vivo Dual-Target CAR-T Therapy in Lymphoma

Stock News
·
Jun 14

GenScript says associate Legend posts Phase 1 proof-of-concept data for LB2501 in vivo CD19/CD20 CAR-T in R/R B-cell lymphoma

Reuters
·
Jun 14

Movement Alert|GenScript Biotech Rises 5.07% in Regular Trading, Legend Biotech In-Vivo CAR-T Data Presented at EHA Conference

Market Focus
·
Jun 12

Movement Alert|GenScript Biotech Falls 5.05% in Regular Trading, CXO Sector Under Sustained Pressure Amid US Investment Restriction Concerns

Market Focus
·
Jun 09

Movement Alert|GenScript Biotech Intraday Decline 7.04%, CXO Sector Sells Off Amid Broader Market Weakness

Market Focus
·
Jun 08

Genscript Biotech adopts fifth-amended Articles; authorises 5 billion shares and formalises hybrid meeting, treasury share and electronic securities rules

Bulletin Express
·
Jun 05

Genscript Biotech AGM Endorses 2025 Financials, Board Re-election and Expanded Share Mandates

Bulletin Express
·
Jun 05

GenScript Biotech held annual general meeting, shareholders adopted amended articles of association

Reuters
·
Jun 05

GENSCRIPT BIO Awards 14.74 Million Restricted Share Units in Total

Stock News
·
Jun 04

GENSCRIPT BIO grants 14.74 million RSUs, equal to 0.67% of share capital

Bulletin Express
·
Jun 04

GenScript Biotech grants 14,736,658 RSUs under 2021 share award scheme

Reuters
·
Jun 04

Hong Kong Market Closes Lower, Optical Communication Stocks Defy Trend, Energy Shares Rally in Afternoon Session

Stock News
·
Jun 03

Genscript Associate to Present Data for Lymphoma Drug at European Conference; Shares Surge 11%

MT Newswires Live
·
Jun 03

Market Chatter: Genscript Biotech Defends Operations Amid Renewed U.S. Lawmaker Scrutiny

MT Newswires Live
·
Jun 03